.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Dow
Medtronic
Novartis
Teva
McKesson
Covington
Accenture
Cantor Fitzgerald
Baxter

Generated: June 23, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide; irbesartan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; irbesartan and what is the scope of hydrochlorothiazide; irbesartan freedom to operate?

Hydrochlorothiazide; irbesartan
is the generic ingredient in two branded drugs marketed by Dr Reddys Labs Ltd, Apotex Inc, Macleods Pharms Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Atlas Pharms Llc, Watson Labs Inc, Sandoz, West-ward Pharms Int, Sanofi Aventis Us, Mylan Pharms Inc, Teva, Alembic Pharms Ltd, Prinston Inc, and Hisun Pharm Hangzhou, and is included in fifteen NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; irbesartan. Eighteen suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: hydrochlorothiazide; irbesartan

Tradenames:2
Patents:1
Applicants:15
NDAs:15
Drug Master File Entries: see list31
Suppliers / Packagers: see list18
Bulk Api Vendors: see list1
Clinical Trials: see list382
Patent Applications: see list13
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide; irbesartan at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide; irbesartan

Tentative approvals for HYDROCHLOROTHIAZIDE; IRBESARTAN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe12.5MG;150MGTABLET;ORAL
► Subscribe► Subscribe12.5MG;300MGTABLET;ORAL
► Subscribe► Subscribe25MG;300MGTABLET; ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL077369-002Mar 30, 2012ABRXNoNo► Subscribe► Subscribe
Watson Labs Inc
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL091539-002Oct 22, 2012DISCNNoNo► Subscribe► Subscribe
West-ward Pharms Int
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL090351-002Oct 15, 2012ABRXNoNo► Subscribe► Subscribe
Hisun Pharm Hangzhou
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL207896-001Oct 14, 2016ABRXNoNo► Subscribe► Subscribe
Teva
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL077369-003Mar 30, 2012DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrochlorothiazide; irbesartan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
AVALIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL020758-002Sep 30, 19975,994,348*PED► Subscribe
Sanofi Aventis Us
AVALIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL020758-003Aug 31, 19985,994,348*PED► Subscribe
Sanofi Aventis Us
AVALIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL020758-004Mar 15, 20055,270,317*PED► Subscribe
Sanofi Aventis Us
AVALIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL020758-001Sep 30, 19975,270,317*PED► Subscribe
Sanofi Aventis Us
AVALIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL020758-003Aug 31, 19985,270,317*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
US Department of Justice
Covington
Deloitte
Federal Trade Commission
Julphar
UBS
Express Scripts
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot